Prosecution Insights
Prosecution Insights
Technology area: Biotechnology & Pharmaceuticals
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready
The Wistar Institute Of Anatomy & Biology has 1 pending office action in the Biotechnology & Pharmaceuticals technology area. The institute's current prosecution profile is highly concentrated, involving 1 distinct examiner and 1 distinct art unit. This indicates that the institute's active patenting efforts are focused on a specific anatomical or biological discovery within a single technical division. The concentration in 1 distinct art unit suggests that the subject matter is highly specialized.
JUEDES, AMY E is the busiest examiner for the portfolio, holding 1 busiest examiner pending action. As the total pending office actions and the busiest examiner pending count are each 1, this examiner is the sole official currently reviewing the institute's active filings. The presence of only 1 distinct examiner means that the outcome of the portfolio's current prosecution phase depends on the interactions with this official. Practitioners should evaluate the past decisions of JUEDES, AMY E to better understand the likely path forward for this single pending biotechnology matter.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| Double-patenting + other | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| JUEDES, AMY E | 1 | 44.7% | +41.9% |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18013542 | CD4+HELPER EPITOPES AND USES TO ENHANCE ANTIGEN-SPECIFIC IMMUNE RESPONSES | JUEDES, AMY E | — |
| Art Unit | Apps |
|---|---|
| 1644 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18013542 | CD4+HELPER EPITOPES AND USES TO ENHANCE ANTIGEN-SPECIFIC IMMUNE RESPONSES | JUEDES, AMY E | 1644 | §102§103§112DP | Final Rejection | — | Pending | Dec 28, 2022 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialThe Wistar Institute Of Anatomy & Biology has 1 pending office actions as of October 2026, spread across 1 art units and 1 examiners.
Amy E Juedes has the most, with 1 of The Wistar Institute Of Anatomy & Biology's pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.